Home・Akcijų sąrašas・Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

17.05 -3.51

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

16.98

Max

17.6

Pagrindiniai rodikliai
By Trading Economics
Pajamos	9.2M 4.6M
Pardavimai	27M 419M
Pelnas, tenkantis vienai akcijai	0.56
Pelno marža	1.103
Darbuotojai	4,427
EBITDA	-35M 28M

Rekomendacijos
By TipRanks
Rekomendacijos	Neutralu
12 mėnesių prognozė	+9.11% upside

Dividendai
By Acuity
Kitas uždarbis	2026-10-29

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-129M 1.4B
Ankstesnė atidarymo kaina	20.56
Ankstesnė uždarymo kaina	17.05

Naujienos nuotaikos

By Acuity

25%

75%

72 / 340 reitingas Healthcare

Integra LifeSciences Holdings Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-06 19:36; UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Wednesday's close. The stock remains below its 20-day moving average.

2026-08-05 19:36; UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Tuesday's close. The stock remains significantly below its 20-day moving average.

2026-08-04 19:46; UTC

Integra Lifesciences Holdings Corp shares are lower during Tuesday's session, approximately 3.60% below the 20-day moving average, with no specific news identified.

2026-08-03 20:51; UTC

Integra Lifesciences Holdings Corp gains in after-market hours, reflecting broader market optimism despite no specific company news. Major indices also show significant increases.

2026-07-31 19:46; UTC

Integra Lifesciences Holdings Corp shares are lower during Friday's session, trading near the lower end of their one-month range with no specific news identified.

2026-07-30 17:41; UTC

Integra Lifesciences Holdings Corp shares are higher today, despite earlier session pullbacks. No specific news was identified to explain the movement.

2026-07-29 21:01; UTC

Integra Lifesciences shares are lower in after-market hours, reflecting a broader decline in U.S. equities amid rising oil prices and geopolitical tensions.

2026-07-28 20:03; UTC

News

Shares of Integra Lifesciences Holdings are higher, supported by UBS's Neutral rating and price target of $19 amid broader Health Care Equipment gains.

2026-07-27 19:51; UTC

Integra Lifesciences Holdings Corp shares are lower today amid notable volatility, despite remaining near the upper end of their one-month trading range.

2026-07-24 19:02; UTC

News

Integra Lifesciences shares are higher today, following a downgrade from Wall Street Zen and a price target increase from Truist Financial to $19.00.

2026-07-21 18:46; UTC

Integra Lifesciences Holdings shares are higher amid broader market recovery, despite a slight pullback from earlier gains. The stock remains above its 20-day moving average.

2026-07-20 19:26; UTC

News

Integra Lifesciences Holdings is lower amid broader market pressure from rising Treasury yields. Investors await upcoming quarterly results after exceeding earnings expectations.

Akcijų palyginimas

Kainos pokytis

Integra LifeSciences Holdings Corp Prognozė

Kainos tikslas

By TipRanks

9.11% į viršų

12 mėnesių prognozė

Vidutinis 19.29 USD 9.11%

Aukščiausias 25 USD

Žemiausias 17 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Integra LifeSciences Holdings Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

9 ratings

Pirkti

Laikyti

Parduoti

Remiantis 9 analitikų, pateikusių Integra LifeSciences Holdings Corp akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Rinkos nuotaikos

By Acuity

72 / 340 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.